ArticleJournal of cell science2026
Interplay between nuclear survivin and the PRC2 complex and its impact on H3K27me3-directed transcriptional repression.
Article in Journal of cell science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Polycomb repressor complex 2 (PRC2) tri-methylates histone 3 at lysine 27 (H3K27me3), a post translational modification that induces heterochromatin formation and transcriptional repression. Survivin (also known as BIRC5) is a nucleocytoplasmic shuttling protein that is kept out of the nucleus in clement conditions, but that accumulates there in times of stress and in certain specialised cells. Although the cytoplasmic functions of survivin are well documented, there is comparatively less understanding of its roles within the nucleus. Here, we investigated whether nuclear survivin can affect transcriptional programming. Using interaction analyses and qPCR, we report that it binds to the enzymatic subunit of PRC2 (EZH2) and H3K27me3, and causes depression of its target genes in a variety of human cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.